Sign inJoin free

Watch / Company News

Market update | News Corp, Telstra, Pro Medicus, Austal, IGO, Integrated Researh, Star Entertainment, EML payments, ASX, Integral Diagnostics

23 Dec 20244:16

Market update | News Corp, Telstra, Pro Medicus, Austal, IGO, Integrated Researh, Star Entertainment, EML payments, ASX, Integral Diagnostics

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

News Corp and Telstra have agreed to sell pay TV broadcaster Foxtel to British sports streaming platform DAZN in a deal totaling $3.4 billion.

Pro Medicus has signed a $30 million 7-year deal with Duly Health and Care in Midwest USA, providing Visage 7 unified imaging platform throughout the company.

Austal has won a $137 million dollar contract with the Australian border force for its additional evolved Cape Class boats.

IGO says there was a major shutdown at its Kwinana refinery in October - with the company experiencing a build-up of lithium hydroxide inventory over recent months.

Integrated Research expects revenue for the first half to come in between $25 and $29 million dollars. That's a drop of 34% on the year.

JPMorgan has exited its stake in embattled casino operator Star Entertainment.

EML payments price is plummeting after news that the company has terminated Managing Director and CEO Ron Hynes’ employment agreement, effective 21 December 2024.

The ASX recommenced trading this morning after a software glitch late last week halted the settlement of transactions.

Citi has resumed coverage on Integral Diagnostics post its merger with Capitol Health with "neutral" rating at a price target of $3 per share.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy